Board of directors

 
 

Peter Benson

Peter Benson – born 1955, Chairman since 2014 and Board member since 2011 – is a Swedish graduate in business administration from Lund University in Sweden and has an MA in Economics from the University of California. Peter Benson is the Managing Partner of Sunstone Capital Life Science Ventures has previously inter alia been Head of Life Science Investments for Vækstfonden (The Danish Growth Fund) and part of Pharmacia AB’s group management.

Other current positions: Board member of Arcoma Aktiebolag, Jollingham AB, Montela Aktiebolag, Opsona Therapeutics Ltd. and Sunstone Capital A/S.

Holdings in Alligator: None

Independent in relation to the Company, its senior management and major shareholders.

Carl Borrebaeck

Carl Borrebaeck – born 1948, Board member since 2001 - is a Swedish graduate engineer from Lund University, Professor at the Department of Immunotechnology and Programme Director of the CREATE Health Translational Cancer Research Centre at Lund University. Carl Borrebaeck is a co-founder of Alligator and is a board member of the Royal Swedish Academy of Engineering Sciences and former Vice-Chancellor of Lund University.

Other current positions: Chairman of Immunovia AB (publ) and SanzaGen AB. Board member of Clinical Laserthermia Systems AB and CB Ocean Capital AB. Deputy Board member of Endo Medical AB. Partner of Immunova HB.

Holdings in Alligator: 1,200,833 shares

Non-independent in relation to the Company and its senior management, but independent in relation to major shareholders.

Ulrika Danielsson

Ulrika Danielsson – born 1972, Board member since 2016 – has an MBA from the Gothenburg School of Business, Economics and Law at the University of Gothenburg, and has been the CFO of Castellum AB (publ) since 2014. She has worked for the Castellum Group in various senior positions since 1998 and has been a member of the corporate management of Castellum since 2006.

Other current positions: Ulrika Danielsson is a Board member and deputy Board member respectively for a number of subsidiaries and second-tier subsidiaries within the Castellum Group.

Holdings in Alligator: None

Independent in relation to the Company, its senior management and major shareholders.

Anders Ekblom

Anders Ekblom – born 1954, Board member since 2017 – is a physician, board certified in anaesthesia and intensive care, dentist and Associate Professor in physiology at the Karolinska Institute. Anders Ekblom has extensive experience from the biopharmaceutical industry globally, including being CEO and president of AstraZeneca AB Sweden.

Other current positions: Chairman of Karolinska University hospital and TFS International AB. Board member of AnaMar AB, Forska!Sverige, Infant Bacterial Therapuetics AB, Mereo Biopharma Group Ltd, Medivir AB, RSPR Pharma AB and Vetenskapsrådet.

Holdings in Alligator: 10,000 shares

Independent in relation to the Company, its senior management and major shareholders.

Kenth Petersson

Kenth Petersson – born 1956, Board member since 2001 – has a BA from Lund University and has long experience of working in both the finance and biotechnology sectors, including as an analyst. He has been a business angel for more than 15 years and has founded a number of biotechnology companies.

Other current positions: Chairman of AlphaBeta Aktiebolag, Biocrine AB, Biocrine Regenative Medicine Aktiebolag and Spiber Technologies AB. Board member of Science Pacific Aktiebolag and Genovis Aktiebolag.

Holdings in Alligator: 408,000 shares

Independent in relation to the Company, its senior management and major shareholders.

Jonas Sjögren

Jonas Sjögren – born 1966, Board member since 2015 – is a Swedish graduate engineer in electrical engineering from Chalmers University of Technology, Registered medical doctor from the Sahlgrenska Academy (Faculty of Health Sciences at the University of Gothenburg), and has an MBA from INSEAD.

Other current positions: Board member of Storytel AB (publ), Orbit E-sport AB, Roxette Photo NV and Omentum SA. Deputy Board member of Execca Allocation AB.

Holdings in Alligator: 4,736,700 shares

Independent in relation to the Company, its senior management and major shareholders.

Laura von Schantz

 
Laura von Schantz - born 1982, board member since 2017 - is a Swedish graduate engineer in biotechnical engineering and has a doctorate in immuno-technology from Lund University. Is the board’s employee representative.

Other current positions: None

Holdings in Alligator: None